{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:16:16Z","timestamp":1782580576998,"version":"3.54.5"},"reference-count":226,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["19UFEL34380251"],"award-info":[{"award-number":["19UFEL34380251"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["17CCRG33671128"],"award-info":[{"award-number":["17CCRG33671128"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15CVGPSD27020012"],"award-info":[{"award-number":["15CVGPSD27020012"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL130356"],"award-info":[{"award-number":["HL130356"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL139680"],"award-info":[{"award-number":["HL139680"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["HL105826"],"award-info":[{"award-number":["HL105826"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR067279"],"award-info":[{"award-number":["AR067279"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002584","name":"American Historical Association","doi-asserted-by":"publisher","award":["19TPA34830084"],"award-info":[{"award-number":["19TPA34830084"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biophys Rev"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12551-020-00725-1","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T07:02:48Z","timestamp":1594537368000},"page":"1065-1084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Genetic, clinical, molecular, and pathogenic aspects of the South Asian\u2013specific polymorphic MYBPC3\u039425bp variant"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-8860","authenticated-orcid":false,"given":"Mohammed","family":"Arif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooneh","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taejeong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshini","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholeh","family":"Bazrafshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perundurai S.","family":"Dhandapany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia G.","family":"Kranias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthivel","family":"Sadayappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,12]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/CIRCULATIONAHA.114.011207","volume":"130","author":"B Adalsteinsdottir","year":"2014","unstructured":"Adalsteinsdottir B et al (2014) Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation. Circulation 130:1158\u20131167. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011207","journal-title":"Circulation"},{"key":"725_CR2","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/S0195-668X(03)00466-4","volume":"24","author":"M Alders","year":"2003","unstructured":"Alders M et al (2003) The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J 24:1848\u20131853","journal-title":"Eur Heart J"},{"key":"725_CR3","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","volume":"72","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM et al (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 72:1677\u20131749. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.053","journal-title":"J Am Coll Cardiol"},{"key":"725_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1073\/pnas.1212708110","volume":"110","author":"HA Al-Khayat","year":"2013","unstructured":"Al-Khayat HA, Kensler RW, Squire JM, Marston SB, Morris EP (2013) Atomic model of the human cardiac muscle myosin filament. Proc Natl Acad Sci U S A 110:318\u2013323. https:\/\/doi.org\/10.1073\/pnas.1212708110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"725_CR5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-019-0248-0","volume":"42","author":"M Arif","year":"2019","unstructured":"Arif M, Sadayappan S, Becker RC, Martin LJ, Urbina EM (2019) Epigenetic modification: a regulatory mechanism in essential hypertension. Hypertens Res 42:1099\u20131113. https:\/\/doi.org\/10.1038\/s41440-019-0248-0","journal-title":"Hypertens Res"},{"key":"725_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/CIRCRESAHA.111.242974","volume":"109","author":"H Ashrafian","year":"2011","unstructured":"Ashrafian H, McKenna WJ, Watkins H (2011) Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res 109:86\u201396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.242974","journal-title":"Circ Res"},{"key":"725_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jmb.2008.09.070","volume":"384","author":"U Bahrudin","year":"2008","unstructured":"Bahrudin U et al (2008) Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. J Mol Biol 384:896\u2013907. https:\/\/doi.org\/10.1016\/j.jmb.2008.09.070","journal-title":"J Mol Biol"},{"key":"725_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jmb.2011.09.006","volume":"413","author":"U Bahrudin","year":"2011","unstructured":"Bahrudin U et al (2011) Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction. J Mol Biol 413:857\u2013878. https:\/\/doi.org\/10.1016\/j.jmb.2011.09.006","journal-title":"J Mol Biol"},{"key":"725_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.yjmcc.2009.11.014","volume":"48","author":"D Barefield","year":"2010","unstructured":"Barefield D, Sadayappan S (2010) Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol 48:866\u2013875. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.11.014","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR10","doi-asserted-by":"publisher","first-page":"H807","DOI":"10.1152\/ajpheart.00913.2013","volume":"306","author":"D Barefield","year":"2014","unstructured":"Barefield D, Kumar M, de Tombe PP, Sadayappan S (2014) Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 306:H807\u2013H815. https:\/\/doi.org\/10.1152\/ajpheart.00913.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"725_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.yjmcc.2014.11.018","volume":"79","author":"D Barefield","year":"2015","unstructured":"Barefield D, Kumar M, Gorham J, Seidman JG, Seidman CE, de Tombe PP, Sadayappan S (2015) Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. J Mol Cell Cardiol 79:234\u2013243. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.11.018","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR12","doi-asserted-by":"publisher","unstructured":"Barefield DY, Lynch TL, Jagadeesan A, Sanagala T, Sadayappan S (2016) High-throughput diagnostic assay for a highly prevalent cardiomyopathy-associated mybpc3 variant. J Mol Biomark Diagn 7. https:\/\/doi.org\/10.4172\/2155-9929.1000303","DOI":"10.4172\/2155-9929.1000303"},{"key":"725_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.yjmcc.2019.03.006","volume":"129","author":"DY Barefield","year":"2019","unstructured":"Barefield DY et al (2019) Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury. J Mol Cell Cardiol 129:236\u2013246. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.03.006","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11010-011-1077-x","volume":"360","author":"MD Bashyam","year":"2012","unstructured":"Bashyam MD et al (2012) A low prevalence of MYH7\/MYBPC3 mutations among familial hypertrophic cardiomyopathy patients in India. Mol Cell Biochem 360:373\u2013382. https:\/\/doi.org\/10.1007\/s11010-011-1077-x","journal-title":"Mol Cell Biochem"},{"key":"725_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/BF01753571","volume":"7","author":"P Bennett","year":"1986","unstructured":"Bennett P, Craig R, Starr R, Offer G (1986) The ultrastructural location of C-protein, X-protein and H-protein in rabbit muscle. J Muscle Res Cell Motil 7:550\u2013567. https:\/\/doi.org\/10.1007\/BF01753571","journal-title":"J Muscle Res Cell Motil"},{"key":"725_CR16","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1172\/JCI70877","volume":"123","author":"MS Bhuiyan","year":"2013","unstructured":"Bhuiyan MS et al (2013) Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest 123:5284\u20135297. https:\/\/doi.org\/10.1172\/JCI70877","journal-title":"J Clin Invest"},{"key":"725_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng1295-438","volume":"11","author":"G Bonne","year":"1995","unstructured":"Bonne G et al (1995) Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 11:438\u2013440","journal-title":"Nat Genet"},{"key":"725_CR18","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/S0140-6736(00)03149-4","volume":"356","author":"M Bristow","year":"2000","unstructured":"Bristow M (2000) Etomoxir: a new approach to treatment of chronic heart failure. Lancet 356:1621\u20131622. https:\/\/doi.org\/10.1016\/S0140-6736(00)03149-4","journal-title":"Lancet"},{"key":"725_CR19","first-page":"2807","volume":"94","author":"MR Bristow","year":"1996","unstructured":"Bristow MR et al (1996) Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circ 94:2807\u20132816","journal-title":"MOCHA Investigators Circ"},{"key":"725_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-2362.2010.02439.x","volume":"41","author":"WP Brouwer","year":"2011","unstructured":"Brouwer WP, van Dijk SJ, Stienen GJ, van Rossum AC, van der Velden J, Germans T (2011) The development of familial hypertrophic cardiomyopathy: from mutation to bedside. Eur J Clin Investig 41:568\u2013578. https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02439.x","journal-title":"Eur J Clin Investig"},{"key":"725_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1006\/abbi.2001.2663","volume":"397","author":"AL Bulteau","year":"2002","unstructured":"Bulteau AL, Szweda LI, Friguet B (2002) Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 397:298\u2013304. https:\/\/doi.org\/10.1006\/abbi.2001.2663","journal-title":"Arch Biochem Biophys"},{"key":"725_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/7651_2018_187","volume":"2002","author":"M Campbell","year":"2019","unstructured":"Campbell M, Chabria M, Figtree GA, Polonchuk L, Gentile C (2019) Stem cell-derived cardiac spheroids as 3D in vitro models of the human heart microenvironment methods. Mol Biol 2002:51\u201359. https:\/\/doi.org\/10.1007\/7651_2018_187","journal-title":"Mol Biol"},{"key":"725_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng0793-311","volume":"4","author":"L Carrier","year":"1993","unstructured":"Carrier L et al (1993) Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet 4:311\u2013313. https:\/\/doi.org\/10.1038\/ng0793-311","journal-title":"Nat Genet"},{"key":"725_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/01.res.0000435859.24609.b3","volume":"80","author":"L Carrier","year":"1997","unstructured":"Carrier L et al (1997) Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 80:427\u2013434","journal-title":"Circ Res"},{"key":"725_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1050-1738(97)00144-8","volume":"8","author":"L Carrier","year":"1998","unstructured":"Carrier L, Bonne G, Schwartz K (1998) Cardiac myosin-binding protein C and hypertrophic cardiomyopathy. Trends Cardiovasc Med 8:151\u2013157. https:\/\/doi.org\/10.1016\/S1050-1738(97)00144-8","journal-title":"Trends Cardiovasc Med"},{"key":"725_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cvr\/cvp247","volume":"85","author":"L Carrier","year":"2010","unstructured":"Carrier L, Schlossarek S, Willis MS, Eschenhagen T (2010) The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res 85:330\u2013338. https:\/\/doi.org\/10.1093\/cvr\/cvp247","journal-title":"Cardiovasc Res"},{"key":"725_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.gene.2015.09.008","volume":"573","author":"L Carrier","year":"2015","unstructured":"Carrier L, Mearini G, Stathopoulou K, Cuello F (2015) Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology. Gene 573:188\u2013197. https:\/\/doi.org\/10.1016\/j.gene.2015.09.008","journal-title":"Gene"},{"key":"725_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature09005","volume":"465","author":"X Carvajal-Vergara","year":"2010","unstructured":"Carvajal-Vergara X et al (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465:808\u2013812. https:\/\/doi.org\/10.1038\/nature09005","journal-title":"Nature"},{"key":"725_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/euhj.1997.0575","volume":"19","author":"P Charron","year":"1998","unstructured":"Charron P et al (1998) Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J 19:139\u2013145. https:\/\/doi.org\/10.1053\/euhj.1997.0575","journal-title":"Eur Heart J"},{"key":"725_CR30","doi-asserted-by":"publisher","first-page":"e14676","DOI":"10.1097\/MD.0000000000014676","volume":"98","author":"X Chen","year":"2019","unstructured":"Chen X, Jiang J, Zhu W, Wu Y, Su M (2019) Next-generation sequencing (NGS) as a molecular diagnostic tool for hypertrophic cardiomyopathy in a Chinese boy due to novel compound heterozygous mutations in the MYBPC3 gene: a case report. Medicine (Baltimore) 98:e14676. https:\/\/doi.org\/10.1097\/MD.0000000000014676","journal-title":"Medicine (Baltimore)"},{"key":"725_CR31","unstructured":"Chowdry AB, Mandegar MA, Benton GM, Naughton BT, Conklin BR (2012) Population Sampling and in vitro Modeling of a 25bp Deletion in MYBPC3 Associated With Hypertrophic Cardiomyopathy. https:\/\/blog.23andme.com\/wp-content\/uploads\/2012\/11\/HCM-ASHG-TTAM.pdf"},{"key":"725_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290146","volume":"13","author":"MW Chung","year":"2003","unstructured":"Chung MW, Tsoutsman T, Semsarian C (2003) Hypertrophic cardiomyopathy: from gene defect to clinical disease. Cell Res 13:9\u201320. https:\/\/doi.org\/10.1038\/sj.cr.7290146","journal-title":"Cell Res"},{"key":"725_CR33","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ejheart.2006.10.001","volume":"8","author":"JG Cleland","year":"2006","unstructured":"Cleland JG, Coletta AP, Clark AL (2006) Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF. Eur J Heart Fail 8:764\u2013766. https:\/\/doi.org\/10.1016\/j.ejheart.2006.10.001","journal-title":"Eur J Heart Fail"},{"key":"725_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/pcad.2002.31585","volume":"44","author":"AJ Coats","year":"2002","unstructured":"Coats AJ (2002) Angiotensin type-1 receptor blockers in heart failure. Prog Cardiovasc Dis 44:231\u2013242","journal-title":"Prog Cardiovasc Dis"},{"key":"725_CR35","doi-asserted-by":"publisher","first-page":"20437","DOI":"10.1073\/pnas.1213027109","volume":"109","author":"BA Colson","year":"2012","unstructured":"Colson BA, Rybakova IN, Prochniewicz E, Moss RL, Thomas DD (2012) Cardiac myosin binding protein-C restricts intrafilament torsional dynamics of actin in a phosphorylation-dependent manner. Proc Natl Acad Sci U S A 109:20437\u201320442. https:\/\/doi.org\/10.1073\/pnas.1213027109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"725_CR36","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1161\/01.CIR.94.11.2800","volume":"94","author":"WS Colucci","year":"1996","unstructured":"Colucci WS et al (1996) Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure US Carvedilol Heart Failure Study Group. Circulation 94:2800\u20132806","journal-title":"Circulation"},{"key":"725_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1098\/rspb.1976.0023","volume":"192","author":"R Craig","year":"1976","unstructured":"Craig R, Offer G (1976) The location of C-protein in rabbit skeletal muscle. Proc R Soc Lond B Biol Sci 192:451\u2013461. https:\/\/doi.org\/10.1098\/rspb.1976.0023","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"725_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jmoldx.2019.01.004","volume":"21","author":"H Daoud","year":"2019","unstructured":"Daoud H et al (2019) Genetic diagnostic testing for inherited cardiomyopathies: considerations for offering multi-gene tests in a health care setting. J Mol Diagn 21:437\u2013448. https:\/\/doi.org\/10.1016\/j.jmoldx.2019.01.004","journal-title":"J Mol Diagn"},{"key":"725_CR39","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/01.RES.0000268412.34364.50","volume":"100","author":"J Davis","year":"2007","unstructured":"Davis J, Wen H, Edwards T, Metzger JM (2007) Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling. Circ Res 100:1494\u20131502","journal-title":"Circ Res"},{"key":"725_CR40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","volume":"165","author":"J Davis","year":"2016","unstructured":"Davis J et al (2016) A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy. Cell 165:1147\u20131159. https:\/\/doi.org\/10.1016\/j.cell.2016.04.002","journal-title":"Cell"},{"key":"725_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1346","volume":"12","author":"SM Day","year":"2006","unstructured":"Day SM et al (2006) Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 12:181\u2013189. https:\/\/doi.org\/10.1038\/nm1346","journal-title":"Nat Med"},{"key":"725_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/ng.309","volume":"41","author":"PS Dhandapany","year":"2009","unstructured":"Dhandapany PS et al (2009) A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet 41:187\u2013191. https:\/\/doi.org\/10.1038\/ng.309","journal-title":"Nat Genet"},{"key":"725_CR43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/VHRM.S2915","volume":"4","author":"S Dodani","year":"2008","unstructured":"Dodani S (2008) Excess coronary artery disease risk in South Asian immigrants: can dysfunctional high-density lipoprotein explain increased risk? Vasc Health Risk Manag 4:953\u2013961","journal-title":"Vasc Health Risk Manag"},{"key":"725_CR44","doi-asserted-by":"publisher","first-page":"18152","DOI":"10.1038\/s41598-019-54665-2","volume":"9","author":"A Dutsch","year":"2019","unstructured":"Dutsch A et al (2019) Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue. Sci Rep 9:18152. https:\/\/doi.org\/10.1038\/s41598-019-54665-2","journal-title":"Sci Rep"},{"key":"725_CR45","first-page":"731","volume":"5","author":"D Eapen","year":"2009","unstructured":"Eapen D, Kalra GL, Merchant N, Arora A, Khan BV (2009) Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag 5:731\u2013743","journal-title":"Vasc Health Risk Manag"},{"key":"725_CR46","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781\u2013788. https:\/\/doi.org\/10.1056\/NEJM199103213241201","journal-title":"N Engl J Med"},{"key":"725_CR47","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","volume":"168","author":"JA Finegold","year":"2013","unstructured":"Finegold JA, Asaria P, Francis DP (2013) Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol 168:934\u2013945. https:\/\/doi.org\/10.1016\/j.ijcard.2012.10.046","journal-title":"Int J Cardiol"},{"key":"725_CR48","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/jmbi.1999.3276","volume":"294","author":"J Flavigny","year":"1999","unstructured":"Flavigny J et al (1999) COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and\/or incorporation in fetal rat cardiomyocytes. J Mol Biol 294:443\u2013456. https:\/\/doi.org\/10.1006\/jmbi.1999.3276","journal-title":"J Mol Biol"},{"key":"725_CR49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cardiores.2003.07.001","volume":"60","author":"J Flavigny","year":"2003","unstructured":"Flavigny J, Robert P, Camelin JC, Schwartz K, Carrier L, Berrebi-Bertrand I (2003) Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathy. Cardiovasc Res 60:388\u2013396","journal-title":"Cardiovasc Res"},{"key":"725_CR50","doi-asserted-by":"publisher","first-page":"e0181842","DOI":"10.1371\/journal.pone.0181842","volume":"12","author":"C Forleo","year":"2017","unstructured":"Forleo C et al (2017) Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies. PLoS One 12:e0181842. https:\/\/doi.org\/10.1371\/journal.pone.0181842","journal-title":"PLoS One"},{"key":"725_CR51","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.yjmcc.2012.03.009","volume":"52","author":"B Fraysse","year":"2012","unstructured":"Fraysse B et al (2012) Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol 52:1299\u20131307. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.03.009","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1432-1033.1996.00317.x","volume":"235","author":"A Freiburg","year":"1996","unstructured":"Freiburg A, Gautel M (1996) A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 235:317\u2013323. https:\/\/doi.org\/10.1111\/j.1432-1033.1996.00317.x","journal-title":"Eur J Biochem"},{"key":"725_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1071-9164(98)90253-6","volume":"4","author":"AH From","year":"1998","unstructured":"From AH (1998) Should manipulation of myocardial substrate utilization patterns be a component of the congestive heart failure therapeutic paradigm? J Card Fail 4:127\u2013129","journal-title":"J Card Fail"},{"key":"725_CR54","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/j.1460-2075.1995.tb07187.x","volume":"14","author":"M Gautel","year":"1995","unstructured":"Gautel M, Zuffardi O, Freiburg A, Labeit S (1995) Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J 14:1952\u20131960","journal-title":"EMBO J"},{"key":"725_CR55","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-i","volume":"62","author":"AA Geisterfer-Lowrance","year":"1990","unstructured":"Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG (1990) A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62:999\u20131006. https:\/\/doi.org\/10.1016\/0092-8674(90)90274-i","journal-title":"Cell"},{"key":"725_CR56","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ et al (2011) 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 124:2761\u20132796. https:\/\/doi.org\/10.1161\/CIR.0b013e318223e230","journal-title":"Circulation"},{"key":"725_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.yjmcc.2007.10.017","volume":"44","author":"CC Glembotski","year":"2008","unstructured":"Glembotski CC (2008) The role of the unfolded protein response in the heart. J Mol Cell Cardiol 44:453\u2013459. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.10.017","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR58","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1253\/circj.cj-14-0628","volume":"78","author":"J Gomez","year":"2014","unstructured":"Gomez J et al (2014) Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing. Circ J 78:2963\u20132971. https:\/\/doi.org\/10.1253\/circj.cj-14-0628","journal-title":"Circ J"},{"key":"725_CR59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.yjmcc.2011.09.011","volume":"52","author":"S Govindan","year":"2012","unstructured":"Govindan S et al (2012) Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol 52:154\u2013164. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.09.011","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR60","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aad3456","volume":"351","author":"EM Green","year":"2016","unstructured":"Green EM et al (2016) A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351:617\u2013621. https:\/\/doi.org\/10.1126\/science.aad3456","journal-title":"Science"},{"key":"725_CR61","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.110.227033","volume":"107","author":"J Groenendyk","year":"2010","unstructured":"Groenendyk J, Sreenivasaiah PK, Kaimdo H, Agellon LB, Michalak M (2010) Biology of endoplasmic reticulum stress in the heart. Circ Res 107:1185\u20131197. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.227033","journal-title":"Circ Res"},{"key":"725_CR62","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1006\/jmbi.1998.2522","volume":"286","author":"M Gruen","year":"1999","unstructured":"Gruen M, Gautel M (1999) Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J Mol Biol 286:933\u2013949. https:\/\/doi.org\/10.1006\/jmbi.1998.2522","journal-title":"J Mol Biol"},{"key":"725_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0828-282X(06)70895-9","volume":"22","author":"M Gupta","year":"2006","unstructured":"Gupta M, Brister S (2006) Is South Asian ethnicity an independent cardiovascular risk factor? Can J Cardiol 22:193\u2013197","journal-title":"Can J Cardiol"},{"key":"725_CR64","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/CIRCRESAHA.115.304760","volume":"115","author":"MK Gupta","year":"2014","unstructured":"Gupta MK, Gulick J, Liu R, Wang X, Molkentin JD, Robbins J (2014) Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes. Circ Res 115:721\u2013729. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.304760","journal-title":"Circ Res"},{"key":"725_CR65","doi-asserted-by":"publisher","first-page":"19862","DOI":"10.1074\/jbc.R114.568477","volume":"289","author":"M Halliday","year":"2014","unstructured":"Halliday M, Radford H, Mallucci GR (2014) Prions: generation and spread versus neurotoxicity. J Biol Chem 289:19862\u201319868. https:\/\/doi.org\/10.1074\/jbc.R114.568477","journal-title":"J Biol Chem"},{"key":"725_CR66","doi-asserted-by":"publisher","unstructured":"Harper AR et al (2020) A re-evaluation of the South Asian MYBPC3(Delta25) intronic deletion in hypertrophic cardiomyopathy. Circ Genom Precis Med. https:\/\/doi.org\/10.1161\/CIRCGEN.119.002783","DOI":"10.1161\/CIRCGEN.119.002783"},{"key":"725_CR67","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCRESAHA.110.231670","volume":"108","author":"SP Harris","year":"2011","unstructured":"Harris SP, Lyons RG, Bezold KL (2011) In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res 108:751\u2013764. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.231670","journal-title":"Circ Res"},{"key":"725_CR68","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1016\/S0021-9258(17)42588-9","volume":"259","author":"HC Hartzell","year":"1984","unstructured":"Hartzell HC, Glass DB (1984) Phosphorylation of purified cardiac muscle C-protein by purified cAMP-dependent and endogenous Ca2+-calmodulin-dependent protein kinases. J Biol Chem 259:15587\u201315596","journal-title":"J Biol Chem"},{"key":"725_CR69","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0021-9258(19)68153-6","volume":"257","author":"HC Hartzell","year":"1982","unstructured":"Hartzell HC, Titus L (1982) Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-Dalton myofibrillar protein in intact cardiac muscle. J Biol Chem 257:2111\u20132120","journal-title":"J Biol Chem"},{"key":"725_CR70","doi-asserted-by":"publisher","unstructured":"Heitner SB et al (2019) Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial. Ann Intern Med. https:\/\/doi.org\/10.7326\/M18-3016","DOI":"10.7326\/M18-3016"},{"key":"725_CR71","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCGENETICS.113.000448","volume":"7","author":"AS Helms","year":"2014","unstructured":"Helms AS et al (2014) Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathy. Circ Cardiovasc Genet 7:434\u2013443. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000448","journal-title":"Circ Cardiovasc Genet"},{"key":"725_CR72","doi-asserted-by":"publisher","unstructured":"Helms AS et al (2020) Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy. JCI Insight 5. https:\/\/doi.org\/10.1172\/jci.insight.133782","DOI":"10.1172\/jci.insight.133782"},{"key":"725_CR73","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jjcc.2010.04.003","volume":"56","author":"N Hitomi","year":"2010","unstructured":"Hitomi N et al (2010) A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Cardiol 56:189\u2013196. https:\/\/doi.org\/10.1016\/j.jjcc.2010.04.003","journal-title":"J Cardiol"},{"key":"725_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jchf.2014.08.003","volume":"3","author":"CY Ho","year":"2015","unstructured":"Ho CY et al (2015) Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression. JACC Heart Fail 3:180\u2013188. https:\/\/doi.org\/10.1016\/j.jchf.2014.08.003","journal-title":"JACC Heart Fail"},{"key":"725_CR75","doi-asserted-by":"publisher","unstructured":"Ho BX, Pek NMQ, Soh BS (2018) Disease modeling using 3D organoids derived from human induced pluripotent stem cells. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19040936","DOI":"10.3390\/ijms19040936"},{"key":"725_CR76","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nprot.2018.006","volume":"13","author":"P Hoang","year":"2018","unstructured":"Hoang P, Wang J, Conklin BR, Healy KE, Ma Z (2018) Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells. Nat Protoc 13:723\u2013737. https:\/\/doi.org\/10.1038\/nprot.2018.006","journal-title":"Nat Protoc"},{"key":"725_CR77","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jemt.22777","volume":"81","author":"MP Hoffman","year":"2018","unstructured":"Hoffman MP, Taylor EN, Aninwene GE 2nd, Sadayappan S, Gilbert RJ (2018) Assessing the multiscale architecture of muscular tissue with Q-space magnetic resonance imaging: review. Microsc Res Tech 81:162\u2013170. https:\/\/doi.org\/10.1002\/jemt.22777","journal-title":"Microsc Res Tech"},{"key":"725_CR78","doi-asserted-by":"publisher","unstructured":"Hossain MB, Elbeck Z, Siga H, Knoll R (2019) Myosin binding protein C (MYBPC) and hypertrophic cardiomyopathy: role of altered C10 domain. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvz167","DOI":"10.1093\/cvr\/cvz167"},{"key":"725_CR79","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1074\/jbc.M111.309591","volume":"287","author":"JW Howarth","year":"2012","unstructured":"Howarth JW, Ramisetti S, Nolan K, Sadayappan S, Rosevear PR (2012) Structural insight into unique cardiac myosin-binding protein-C motif: a partially folded domain. J Biol Chem 287:8254\u20138262. https:\/\/doi.org\/10.1074\/jbc.M111.309591","journal-title":"J Biol Chem"},{"key":"725_CR80","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2:231\u2013237. https:\/\/doi.org\/10.1242\/dmm.001180","journal-title":"Dis Model Mech"},{"key":"725_CR81","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/hmg\/ddr424","volume":"20","author":"HP Huang","year":"2011","unstructured":"Huang HP et al (2011) Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Hum Mol Genet 20:4851\u20134864. https:\/\/doi.org\/10.1093\/hmg\/ddr424","journal-title":"Hum Mol Genet"},{"key":"725_CR82","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.yjmcc.2010.01.011","volume":"48","author":"S Huke","year":"2010","unstructured":"Huke S, Knollmann BC (2010) Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility. J Mol Cell Cardiol 48:824\u2013833. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.01.011","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR83","unstructured":"Hunt SA et al. (2001) ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America Circulation 104:2996\u20133007"},{"key":"725_CR84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/07853890.2012.671534","volume":"45","author":"P Jaaskelainen","year":"2013","unstructured":"Jaaskelainen P et al (2013) Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population. Ann Med 45:85\u201390. https:\/\/doi.org\/10.3109\/07853890.2012.671534","journal-title":"Ann Med"},{"key":"725_CR85","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10974-009-9174-0","volume":"29","author":"A Jacques","year":"2008","unstructured":"Jacques A, Hoskins AC, Kentish JC, Marston SB (2008) From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene. J Muscle Res Cell Motil 29:239\u2013246. https:\/\/doi.org\/10.1007\/s10974-009-9174-0","journal-title":"J Muscle Res Cell Motil"},{"key":"725_CR86","doi-asserted-by":"publisher","first-page":"9913","DOI":"10.1074\/jbc.R110.171801","volume":"286","author":"J James","year":"2011","unstructured":"James J, Robbins J (2011) Signaling and myosin-binding protein C. J Biol Chem 286:9913\u20139919. https:\/\/doi.org\/10.1074\/jbc.R110.171801","journal-title":"J Biol Chem"},{"key":"725_CR87","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1161\/01.CIR.0000164233.09448.B1","volume":"111","author":"J James","year":"2005","unstructured":"James J et al (2005) Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. Circulation 111:2339\u20132346. https:\/\/doi.org\/10.1161\/01.CIR.0000164233.09448.B1","journal-title":"Circulation"},{"key":"725_CR88","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.1236921","volume":"342","author":"J Jiang","year":"2013","unstructured":"Jiang J, Wakimoto H, Seidman JG, Seidman CE (2013) Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy. Science 342:111\u2013114. https:\/\/doi.org\/10.1126\/science.1236921","journal-title":"Science"},{"key":"725_CR89","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jcin.2013.11.013","volume":"7","author":"DA Jones","year":"2014","unstructured":"Jones DA et al (2014) Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database. JACC Cardiovasc Interv 7:362\u2013371. https:\/\/doi.org\/10.1016\/j.jcin.2013.11.013","journal-title":"JACC Cardiovasc Interv"},{"key":"725_CR90","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cardfail.2015.04.010","volume":"21","author":"F Kamdar","year":"2015","unstructured":"Kamdar F, Klaassen Kamdar A, Koyano-Nakagawa N, Garry MG, Garry DJ (2015) Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies. J Card Fail 21:761\u2013770. https:\/\/doi.org\/10.1016\/j.cardfail.2015.04.010","journal-title":"J Card Fail"},{"key":"725_CR91","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/0735-1097(89)90596-2","volume":"13","author":"R Karam","year":"1989","unstructured":"Karam R, Lever HM, Healy BP (1989) Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol 13:580\u2013584. https:\/\/doi.org\/10.1016\/0735-1097(89)90596-2","journal-title":"J Am Coll Cardiol"},{"key":"725_CR92","doi-asserted-by":"publisher","first-page":"943162","DOI":"10.1155\/2014\/943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur J (2014) A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:943162. https:\/\/doi.org\/10.1155\/2014\/943162","journal-title":"Cardiol Res Pract"},{"key":"725_CR93","doi-asserted-by":"publisher","first-page":"16571","DOI":"10.1074\/jbc.M117.776815","volume":"292","author":"RF Kawas","year":"2017","unstructured":"Kawas RF, Anderson RL, Ingle SRB, Song Y, Sran AS, Rodriguez HM (2017) A small-molecule modulator of cardiac myosin acts on multiple stages of the myosin chemomechanical cycle. J Biol Chem 292:16571\u201316577. https:\/\/doi.org\/10.1074\/jbc.M117.776815","journal-title":"J Biol Chem"},{"key":"725_CR94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jsb.2010.12.003","volume":"174","author":"RW Kensler","year":"2011","unstructured":"Kensler RW, Shaffer JF, Harris SP (2011) Binding of the N-terminal fragment C0-C2 of cardiac MyBP-C to cardiac F-actin. J Struct Biol 174:44\u201351. https:\/\/doi.org\/10.1016\/j.jsb.2010.12.003","journal-title":"J Struct Biol"},{"key":"725_CR95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCRESAHA.110.222919","volume":"107","author":"M Kitakaze","year":"2010","unstructured":"Kitakaze M, Tsukamoto O (2010) What is the role of ER stress in the heart? Introduction and series overview. Circ Res 107:15\u201318. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.222919","journal-title":"Circ Res"},{"key":"725_CR96","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10974-011-9281-6","volume":"33","author":"R Knoll","year":"2012","unstructured":"Knoll R (2012) Myosin binding protein C: implications for signal-transduction. J Muscle Res Cell Motil 33:31\u201342. https:\/\/doi.org\/10.1007\/s10974-011-9281-6","journal-title":"J Muscle Res Cell Motil"},{"key":"725_CR97","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCRESAHA.112.300567","volume":"112","author":"BC Knollmann","year":"2013","unstructured":"Knollmann BC (2013) Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ Res 112:969\u2013976; discussion 976. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.300567","journal-title":"Circ Res"},{"key":"725_CR98","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yjmcc.2013.04.012","volume":"60","author":"V Kooij","year":"2013","unstructured":"Kooij V, Holewinski RJ, Murphy AM, Van Eyk JE (2013) Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts. J Mol Cell Cardiol 60:116\u2013120. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.04.012","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR99","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fphys.2016.00499","volume":"7","author":"J Kraker","year":"2016","unstructured":"Kraker J, Viswanathan SK, Knoll R, Sadayappan S (2016) Recent advances in the molecular genetics of familial hypertrophic cardiomyopathy in South Asian descendants. Front Physiol 7:499. https:\/\/doi.org\/10.3389\/fphys.2016.00499","journal-title":"Front Physiol"},{"key":"725_CR100","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/0002-8703(86)90475-8","volume":"112","author":"MJ Krell","year":"1986","unstructured":"Krell MJ et al (1986) Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J 112:787\u2013791","journal-title":"Am Heart J"},{"key":"725_CR101","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.jacc.2005.05.087","volume":"46","author":"T Kubo","year":"2005","unstructured":"Kubo T et al (2005) Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac myosin-binding protein C gene among Japanese. J Am Coll Cardiol 46:1737\u20131743. https:\/\/doi.org\/10.1016\/j.jacc.2005.05.087","journal-title":"J Am Coll Cardiol"},{"key":"725_CR102","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1085\/jgp.200308941","volume":"122","author":"I Kulikovskaya","year":"2003","unstructured":"Kulikovskaya I, McClellan G, Flavigny J, Carrier L, Winegrad S (2003a) Effect of MyBP-C binding to actin on contractility in heart muscle. J Gen Physiol 122:761\u2013774. https:\/\/doi.org\/10.1085\/jgp.200308941","journal-title":"J Gen Physiol"},{"key":"725_CR103","doi-asserted-by":"publisher","first-page":"H857","DOI":"10.1152\/ajpheart.00841.2002","volume":"285","author":"I Kulikovskaya","year":"2003","unstructured":"Kulikovskaya I, McClellan G, Levine R, Winegrad S (2003b) Effect of extraction of myosin binding protein C on contractility of rat heart. Am J Physiol Heart Circ Physiol 285:H857\u2013H865. https:\/\/doi.org\/10.1152\/ajpheart.00841.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"725_CR104","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12041-016-0623-4","volume":"95","author":"S Kumar","year":"2016","unstructured":"Kumar S et al (2016) Role of common sarcomeric gene polymorphisms in genetic susceptibility to left ventricular dysfunction. J Genet 95:263\u2013272","journal-title":"J Genet"},{"key":"725_CR105","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00424-013-1417-7","volume":"466","author":"DW Kuster","year":"2014","unstructured":"Kuster DW, Sadayappan S (2014) MYBPC3\u2019s alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation. Pflugers Arch 466:207\u2013213. https:\/\/doi.org\/10.1007\/s00424-013-1417-7","journal-title":"Pflugers Arch"},{"key":"725_CR106","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1074\/jbc.M114.607911","volume":"290","author":"DW Kuster","year":"2015","unstructured":"Kuster DW, Govindan S, Springer TI, Martin JL, Finley NL, Sadayappan S (2015) A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction. J Biol Chem 290:5855\u20135867. https:\/\/doi.org\/10.1074\/jbc.M114.607911","journal-title":"J Biol Chem"},{"key":"725_CR107","doi-asserted-by":"publisher","unstructured":"Kuster DWD et al (2019) Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvz111","DOI":"10.1093\/cvr\/cvz111"},{"key":"725_CR108","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4161\/org.28918","volume":"10","author":"Y Li","year":"2014","unstructured":"Li Y, Xu C, Ma T (2014) In vitro organogenesis from pluripotent stem cells. Organogenesis 10:159\u2013163. https:\/\/doi.org\/10.4161\/org.28918","journal-title":"Organogenesis"},{"key":"725_CR109","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2016.09.003","volume":"99","author":"C Lipps","year":"2016","unstructured":"Lipps C et al (2016) N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro. J Mol Cell Cardiol 99:47\u201356. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.09.003","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR110","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1517\/14728222.2014.918605","volume":"18","author":"M Liu","year":"2014","unstructured":"Liu M, Dudley SC Jr (2014) Targeting the unfolded protein response in heart diseases. Expert Opin Ther Targets 18:719\u2013723. https:\/\/doi.org\/10.1517\/14728222.2014.918605","journal-title":"Expert Opin Ther Targets"},{"key":"725_CR111","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23305","volume":"548","author":"H Ma","year":"2017","unstructured":"Ma H et al (2017) Correction of a pathogenic gene mutation in human embryos. Nature 548:413\u2013419. https:\/\/doi.org\/10.1038\/nature23305","journal-title":"Nature"},{"key":"725_CR112","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1172\/JCI118154","volume":"96","author":"CA MacRae","year":"1995","unstructured":"MacRae CA et al (1995) Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 96:1216\u20131220. https:\/\/doi.org\/10.1172\/JCI118154","journal-title":"J Clin Invest"},{"key":"725_CR113","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/CIRCRESAHA.109.212639","volume":"6","author":"A Maloyan","year":"2010","unstructured":"Maloyan A, Robbins J (2010) Autophagy in desmin-related cardiomyopathy: thoughts at the halfway point. Autophagy 6:665\u2013666. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.212639","journal-title":"Autophagy"},{"key":"725_CR114","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00424-013-1412-z","volume":"466","author":"R Mamidi","year":"2014","unstructured":"Mamidi R, Li J, Gresham KS, Stelzer JE (2014) Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy. Pflugers Arch 466:225\u2013230. https:\/\/doi.org\/10.1007\/s00424-013-1412-z","journal-title":"Pflugers Arch"},{"key":"725_CR115","doi-asserted-by":"publisher","first-page":"e009627","DOI":"10.1161\/JAHA.118.009627","volume":"7","author":"R Mamidi","year":"2018","unstructured":"Mamidi R, Li J, Doh CY, Verma S, Stelzer JE (2018) Impact of the myosin modulator mavacamten on force generation and cross-bridge behavior in a murine model of hypercontractility. J Am Heart Assoc 7:e009627. https:\/\/doi.org\/10.1161\/JAHA.118.009627","journal-title":"J Am Heart Assoc"},{"key":"725_CR116","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0735-1097(01)01389-4","volume":"38","author":"AJ Marian","year":"2001","unstructured":"Marian AJ (2001) On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture. J Am Coll Cardiol 38:331\u2013334. https:\/\/doi.org\/10.1016\/s0735-1097(01)01389-4","journal-title":"J Am Coll Cardiol"},{"key":"725_CR117","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0733-8651(05)70273-3","volume":"14","author":"BJ Maron","year":"1996","unstructured":"Maron BJ (1996) Triggers for sudden cardiac death in the athlete. Cardiol Clin 14:195\u2013210. https:\/\/doi.org\/10.1016\/s0733-8651(05)70273-3","journal-title":"Cardiol Clin"},{"key":"725_CR118","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","volume":"105","author":"S Marston","year":"2009","unstructured":"Marston S et al (2009) Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 105:219\u2013222. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.202440","journal-title":"Circ Res"},{"key":"725_CR119","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.actbio.2017.03.023","volume":"54","author":"CR Marti-Figueroa","year":"2017","unstructured":"Marti-Figueroa CR, Ashton RS (2017) The case for applying tissue engineering methodologies to instruct human organoid morphogenesis. Acta Biomater 54:35\u201344. https:\/\/doi.org\/10.1016\/j.actbio.2017.03.023","journal-title":"Acta Biomater"},{"key":"725_CR120","doi-asserted-by":"publisher","first-page":"H327","DOI":"10.1152\/ajpheart.00688.2017","volume":"315","author":"S Mattapally","year":"2018","unstructured":"Mattapally S et al (2018) Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice. Am J Physiol Heart Circ Physiol 315:H327\u2013H339. https:\/\/doi.org\/10.1152\/ajpheart.00688.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"725_CR121","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1172\/JCI7377","volume":"104","author":"BK McConnell","year":"1999","unstructured":"McConnell BK et al (1999) Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 104:1235\u20131244. https:\/\/doi.org\/10.1172\/JCI7377","journal-title":"J Clin Invest"},{"key":"725_CR122","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1253\/circj.CJ-15-0536","volume":"79","author":"EM McNally","year":"2015","unstructured":"McNally EM, Puckelwartz MJ (2015) Genetic variation in cardiomyopathy and cardiovascular disorders. Circ J 79:1409\u20131415. https:\/\/doi.org\/10.1253\/circj.CJ-15-0536","journal-title":"Circ J"},{"key":"725_CR123","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2015.01.013","volume":"21","author":"EM McNally","year":"2015","unstructured":"McNally EM, Barefield DY, Puckelwartz MJ (2015) The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab 21:174\u2013182. https:\/\/doi.org\/10.1016\/j.cmet.2015.01.013","journal-title":"Cell Metab"},{"key":"725_CR124","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2016.03.009","volume":"94","author":"JW McNamara","year":"2016","unstructured":"McNamara JW et al (2016) Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes. J Mol Cell Cardiol 94:65\u201371. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.03.009","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR125","doi-asserted-by":"publisher","first-page":"e0180064","DOI":"10.1371\/journal.pone.0180064","volume":"12","author":"JW McNamara","year":"2017","unstructured":"McNamara JW et al (2017) MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy. PLoS One 12:e0180064. https:\/\/doi.org\/10.1371\/journal.pone.0180064","journal-title":"PLoS One"},{"key":"725_CR126","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1038\/ncomms6515","volume":"5","author":"G Mearini","year":"2014","unstructured":"Mearini G et al (2014) Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice. Nat Commun 5:5515. https:\/\/doi.org\/10.1038\/ncomms6515","journal-title":"Nat Commun"},{"key":"725_CR127","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCHEARTFAILURE.112.968941","volume":"5","author":"S Merkulov","year":"2012","unstructured":"Merkulov S, Chen X, Chandler MP, Stelzer JE (2012) In vivo cardiac myosin binding protein-C gene transfer rescues myofilament contractile dysfunction in cardiac myosin binding protein-C null mice. Circ Heart Fail 5:635\u2013644. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.968941","journal-title":"Circ Heart Fail"},{"key":"725_CR128","doi-asserted-by":"publisher","unstructured":"Michels M et al (2009) Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehp306","DOI":"10.1093\/eurheartj\/ehp306"},{"key":"725_CR129","doi-asserted-by":"publisher","first-page":"E8372","DOI":"10.1073\/pnas.1707316114","volume":"114","author":"RJ Mills","year":"2017","unstructured":"Mills RJ et al (2017) Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc Natl Acad Sci U S A 114:E8372\u2013E8381. https:\/\/doi.org\/10.1073\/pnas.1707316114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"725_CR130","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.stem.2019.03.009","volume":"24","author":"RJ Mills","year":"2019","unstructured":"Mills RJ et al (2019) Drug screening in human PSC-cardiac organoids identifies pro-proliferative compounds acting via the mevalonate pathway. Cell Stem Cell 24:895\u2013907 e896. https:\/\/doi.org\/10.1016\/j.stem.2019.03.009","journal-title":"Cell Stem Cell"},{"key":"725_CR131","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.yjmcc.2009.10.026","volume":"48","author":"T Minamino","year":"2010","unstructured":"Minamino T, Kitakaze M (2010) ER stress in cardiovascular disease. J Mol Cell Cardiol 48:1105\u20131110. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.10.026","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR132","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/CIRCRESAHA.110.227819","volume":"107","author":"T Minamino","year":"2010","unstructured":"Minamino T, Komuro I, Kitakaze M (2010) Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res 107:1071\u20131082. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.227819","journal-title":"Circ Res"},{"key":"725_CR133","doi-asserted-by":"publisher","unstructured":"Moretti A, Laugwitz KL, Dorn T, Sinnecker D, Mummery C (2013) Pluripotent stem cell models of human heart disease. Cold Spring Harb Perspect Med:3. https:\/\/doi.org\/10.1101\/cshperspect.a014027","DOI":"10.1101\/cshperspect.a014027"},{"key":"725_CR134","doi-asserted-by":"publisher","unstructured":"Morimoto S (2008) Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 77:659\u2013666 doi:https:\/\/doi.org\/10.1093\/cvr\/cvm084","DOI":"10.1093\/cvr\/cvm084"},{"key":"725_CR135","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa075463","volume":"358","author":"H Morita","year":"2008","unstructured":"Morita H et al (2008) Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 358:1899\u20131908. https:\/\/doi.org\/10.1056\/NEJMoa075463","journal-title":"N Engl J Med"},{"key":"725_CR136","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jmb.2011.05.010","volume":"410","author":"JY Mun","year":"2011","unstructured":"Mun JY, Gulick J, Robbins J, Woodhead J, Lehman W, Craig R (2011) Electron microscopy and 3D reconstruction of F-actin decorated with cardiac myosin-binding protein C (cMyBP-C). J Mol Biol 410:214\u2013225. https:\/\/doi.org\/10.1016\/j.jmb.2011.05.010","journal-title":"J Mol Biol"},{"key":"725_CR137","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2004.11.053","volume":"45","author":"RT Murphy","year":"2005","unstructured":"Murphy RT et al (2005) Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. J Am Coll Cardiol 45:922\u2013930. https:\/\/doi.org\/10.1016\/j.jacc.2004.11.053","journal-title":"J Am Coll Cardiol"},{"key":"725_CR138","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/cvr\/cvw026","volume":"110","author":"A Najafi","year":"2016","unstructured":"Najafi A et al (2016) Selective phosphorylation of PKA targets after beta-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model. Cardiovasc Res 110:200\u2013214. https:\/\/doi.org\/10.1093\/cvr\/cvw026","journal-title":"Cardiovasc Res"},{"key":"725_CR139","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","volume":"338","author":"H Niimura","year":"1998","unstructured":"Niimura H et al (1998) Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338:1248\u20131257. https:\/\/doi.org\/10.1056\/NEJM199804303381802","journal-title":"N Engl J Med"},{"key":"725_CR140","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/hc0402.102990","volume":"105","author":"H Niimura","year":"2002","unstructured":"Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE (2002) Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105:446\u2013451","journal-title":"Circulation"},{"key":"725_CR141","doi-asserted-by":"publisher","first-page":"1900344","DOI":"10.1002\/advs.201900344","volume":"6","author":"N Noor","year":"2019","unstructured":"Noor N, Shapira A, Edri R, Gal I, Wertheim L, Dvir T (2019) 3D printing of personalized thick and perfusable cardiac patches and hearts. Adv Sci (Weinh) 6:1900344. https:\/\/doi.org\/10.1002\/advs.201900344","journal-title":"Adv Sci (Weinh)"},{"key":"725_CR142","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.cr.7290208","volume":"14","author":"CE Oakley","year":"2004","unstructured":"Oakley CE, Hambly BD, Curmi PM, Brown LJ (2004) Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy. Cell Res 14:95\u2013110. https:\/\/doi.org\/10.1038\/sj.cr.7290208","journal-title":"Cell Res"},{"key":"725_CR143","doi-asserted-by":"publisher","first-page":"23787","DOI":"10.1074\/jbc.274.34.23787","volume":"274","author":"K Okada","year":"1999","unstructured":"Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K (1999) 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 274:23787\u201323793. https:\/\/doi.org\/10.1074\/jbc.274.34.23787","journal-title":"J Biol Chem"},{"key":"725_CR144","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.123.3.619","volume":"123","author":"T Okagaki","year":"1993","unstructured":"Okagaki T, Weber FE, Fischman DA, Vaughan KT, Mikawa T, Reinach FC (1993) The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J Cell Biol 123:619\u2013626. https:\/\/doi.org\/10.1083\/jcb.123.3.619","journal-title":"J Cell Biol"},{"key":"725_CR145","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1136\/hrt.2010.200402","volume":"96","author":"MJ Oliva-Sandoval","year":"2010","unstructured":"Oliva-Sandoval MJ et al (2010) Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3. Heart 96:1980\u20131984. https:\/\/doi.org\/10.1136\/hrt.2010.200402","journal-title":"Heart"},{"key":"725_CR146","doi-asserted-by":"publisher","unstructured":"Omariba DW (2015) Immigration, ethnicity, and avoidable mortality in Canada, 1991-2006. Ethn Health:1\u201328. https:\/\/doi.org\/10.1080\/13557858.2014.995155","DOI":"10.1080\/13557858.2014.995155"},{"key":"725_CR147","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCGENETICS.111.960831","volume":"5","author":"SP Page","year":"2012","unstructured":"Page SP et al (2012) Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet 5:156\u2013166. https:\/\/doi.org\/10.1161\/CIRCGENETICS.111.960831","journal-title":"Circ Cardiovasc Genet"},{"key":"725_CR148","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1096\/fj.08-121996","volume":"23","author":"NJ Palpant","year":"2009","unstructured":"Palpant NJ, D'Alecy LG, Metzger JM (2009) Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo. FASEB J 23:1529\u20131540. https:\/\/doi.org\/10.1096\/fj.08-121996","journal-title":"FASEB J"},{"issue":"Suppl 1","key":"725_CR149","first-page":"37","volume":"17","author":"WH Pan","year":"2008","unstructured":"Pan WH, Yeh WT, Weng LC (2008) Epidemiology of metabolic syndrome in Asia Asia. Pac J Clin Nutr 17(Suppl 1):37\u201342","journal-title":"Pac J Clin Nutr"},{"key":"725_CR150","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4161\/auto.7.10.16882","volume":"7","author":"JS Pattison","year":"2011","unstructured":"Pattison JS, Robbins J (2011) Autophagy and proteotoxicity in cardiomyocytes. Autophagy 7:1259\u20131260. https:\/\/doi.org\/10.4161\/auto.7.10.16882","journal-title":"Autophagy"},{"key":"725_CR151","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.109.904557","volume":"121","author":"JM Predmore","year":"2010","unstructured":"Predmore JM et al (2010) Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121:997\u20131004. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.904557","journal-title":"Circulation"},{"key":"725_CR152","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1126\/science.1223602","volume":"337","author":"MJ Previs","year":"2012","unstructured":"Previs MJ, Beck Previs S, Gulick J, Robbins J, Warshaw DM (2012) Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science 337:1215\u20131218. https:\/\/doi.org\/10.1126\/science.1223602","journal-title":"Science"},{"key":"725_CR153","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.omtn.2017.05.008","volume":"7","author":"M Prondzynski","year":"2017","unstructured":"Prondzynski M et al (2017) Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-derived cardiomyocytes. Mol Ther Nucleic Acids 7:475\u2013486. https:\/\/doi.org\/10.1016\/j.omtn.2017.05.008","journal-title":"Mol Ther Nucleic Acids"},{"key":"725_CR154","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00424-018-2173-5","volume":"471","author":"M Prondzynski","year":"2019","unstructured":"Prondzynski M, Mearini G, Carrier L (2019) Gene therapy strategies in the treatment of hypertrophic cardiomyopathy. Pflugers Arch 471:807\u2013815. https:\/\/doi.org\/10.1007\/s00424-018-2173-5","journal-title":"Pflugers Arch"},{"key":"725_CR155","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1751-7176.2012.00652.x","volume":"14","author":"CV Ram","year":"2012","unstructured":"Ram CV, Farmer JA (2012) Metabolic syndrome in South Asians. J Clin Hypertens (Greenwich) 14:561\u2013565. https:\/\/doi.org\/10.1111\/j.1751-7176.2012.00652.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"725_CR156","doi-asserted-by":"publisher","first-page":"12650","DOI":"10.1074\/jbc.M110.156646","volume":"286","author":"J Ratti","year":"2011","unstructured":"Ratti J, Rostkova E, Gautel M, Pfuhl M (2011) Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck? J Biol Chem 286:12650\u201312658. https:\/\/doi.org\/10.1074\/jbc.M110.156646","journal-title":"J Biol Chem"},{"key":"725_CR157","doi-asserted-by":"publisher","first-page":"35846","DOI":"10.1074\/jbc.M606949200","volume":"281","author":"MV Razumova","year":"2006","unstructured":"Razumova MV, Shaffer JF, Tu AY, Flint GV, Regnier M, Harris SP (2006) Effects of the N-terminal domains of myosin binding protein-C in an in vitro motility assay: evidence for long-lived cross-bridges. J Biol Chem 281:35846\u201335854. https:\/\/doi.org\/10.1074\/jbc.M606949200","journal-title":"J Biol Chem"},{"key":"725_CR158","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.113.301225","volume":"113","author":"MA Razzaque","year":"2013","unstructured":"Razzaque MA, Gupta M, Osinska H, Gulick J, Blaxall BC, Robbins J (2013) An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure. Circ Res 113:553\u2013561. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301225","journal-title":"Circ Res"},{"key":"725_CR159","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.biomaterials.2017.07.021","volume":"142","author":"DJ Richards","year":"2017","unstructured":"Richards DJ et al (2017) Inspiration from heart development: biomimetic development of functional human cardiac organoids. Biomaterials 142:112\u2013123. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.07.021","journal-title":"Biomaterials"},{"key":"725_CR160","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/CIRCHEARTFAILURE.114.001550","volume":"8","author":"PC Rosas","year":"2015","unstructured":"Rosas PC et al (2015) Phosphorylation of cardiac myosin-binding protein-C is a critical mediator of diastolic function. Circ Heart Fail 8:582\u2013594. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001550","journal-title":"Circ Heart Fail"},{"key":"725_CR161","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jacbts.2019.06.003","volume":"4","author":"PC Rosas","year":"2019","unstructured":"Rosas PC, Warren CM, Creed HA, Trzeciakowski JP, Solaro RJ, Tong CW (2019) Cardiac myosin binding protein-C phosphorylation mitigates age-related cardiac dysfunction: hope for better aging? JACC Basic Transl Sci 4:817\u2013830. https:\/\/doi.org\/10.1016\/j.jacbts.2019.06.003","journal-title":"JACC Basic Transl Sci"},{"key":"725_CR162","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.tcm.2016.05.001","volume":"26","author":"SB Ross","year":"2016","unstructured":"Ross SB, Fraser ST, Semsarian C (2016) Induced pluripotent stem cells in the inherited cardiomyopathies: from disease mechanisms to novel therapies. Trends Cardiovasc Med 26:663\u2013672. https:\/\/doi.org\/10.1016\/j.tcm.2016.05.001","journal-title":"Trends Cardiovasc Med"},{"key":"725_CR163","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1172\/JCI119555","volume":"100","author":"W Rottbauer","year":"1997","unstructured":"Rottbauer W et al (1997) Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest 100:475\u2013482. https:\/\/doi.org\/10.1172\/JCI119555","journal-title":"J Clin Invest"},{"key":"725_CR164","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1388-9842(01)00183-0","volume":"4","author":"HH Sabbah","year":"2002","unstructured":"Sabbah HH, Stanley WC (2002) Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure. Eur J Heart Fail 4:3\u20136","journal-title":"Eur J Heart Fail"},{"key":"725_CR165","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12551-012-0067-x","volume":"4","author":"S Sadayappan","year":"2012","unstructured":"Sadayappan S, de Tombe PP (2012) Cardiac myosin binding protein-C: redefining its structure and function. Biophys Rev 4:93\u2013106. https:\/\/doi.org\/10.1007\/s12551-012-0067-x","journal-title":"Biophys Rev"},{"key":"725_CR166","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00424-013-1396-8","volume":"466","author":"S Sadayappan","year":"2014","unstructured":"Sadayappan S, de Tombe PP (2014) Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: a special mini review series. Pflugers Arch 466:195\u2013200. https:\/\/doi.org\/10.1007\/s00424-013-1396-8","journal-title":"Pflugers Arch"},{"key":"725_CR167","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1161\/01.RES.0000190605.79013.4d","volume":"97","author":"S Sadayappan","year":"2005","unstructured":"Sadayappan S et al (2005) Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res 97:1156\u20131163. https:\/\/doi.org\/10.1161\/01.RES.0000190605.79013.4d","journal-title":"Circ Res"},{"key":"725_CR168","doi-asserted-by":"publisher","first-page":"16918","DOI":"10.1073\/pnas.0607069103","volume":"103","author":"S Sadayappan","year":"2006","unstructured":"Sadayappan S et al (2006) Cardiac myosin binding protein C phosphorylation is cardioprotective. Proc Natl Acad Sci U S A 103:16918\u201316923. https:\/\/doi.org\/10.1073\/pnas.0607069103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"725_CR169","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.108.798983","volume":"119","author":"S Sadayappan","year":"2009","unstructured":"Sadayappan S, Gulick J, Klevitsky R, Lorenz JN, Sargent M, Molkentin JD, Robbins J (2009) Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background. Circulation 119:1253\u20131262. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.798983","journal-title":"Circulation"},{"key":"725_CR170","doi-asserted-by":"publisher","first-page":"e002986","DOI":"10.1161\/CIRCGEN.120.002986","volume":"13","author":"S Sadayappan","year":"2020","unstructured":"Sadayappan S, Puckelwartz MJ, McNally EM (2020) South Asian-specific MYBPC3(Delta25bp) intronic deletion and its role in cardiomyopathies and heart failure. Circ Genom Precis Med 13:e002986. https:\/\/doi.org\/10.1161\/CIRCGEN.120.002986","journal-title":"Circ Genom Precis Med"},{"key":"725_CR171","doi-asserted-by":"publisher","first-page":"A105","DOI":"10.1016\/S0022-2828(01)90416-X","volume":"33","author":"S Sakthivel","year":"2001","unstructured":"Sakthivel S et al (2001) Novel mutations in MYH7 and MYBPC3 of an Indian family causing hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:A105 (Abstract)","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR172","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.109.216291","volume":"106","author":"AJ Saltzman","year":"2010","unstructured":"Saltzman AJ et al (2010) Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy. Circ Res 106:1549\u20131552. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.216291","journal-title":"Circ Res"},{"key":"725_CR173","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/01.CIR.0000133390.12306.C7","volume":"110","author":"S Sanada","year":"2004","unstructured":"Sanada S et al (2004) Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 110:51\u201357. https:\/\/doi.org\/10.1161\/01.CIR.0000133390.12306.C7","journal-title":"Circulation"},{"key":"725_CR174","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cardiores.2005.01.004","volume":"66","author":"A Sarikas","year":"2005","unstructured":"Sarikas A et al (2005) Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res 66:33\u201344. https:\/\/doi.org\/10.1016\/j.cardiores.2005.01.004","journal-title":"Cardiovasc Res"},{"key":"725_CR175","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.yjmcc.2011.01.014","volume":"50","author":"S Schlossarek","year":"2011","unstructured":"Schlossarek S, Mearini G, Carrier L (2011) Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J Mol Cell Cardiol 50:613\u2013620. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.01.014","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR176","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00395-011-0235-3","volume":"107","author":"S Schlossarek","year":"2012","unstructured":"Schlossarek S, Englmann DR, Sultan KR, Sauer M, Eschenhagen T, Carrier L (2012) Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy. Basic Res Cardiol 107:235. https:\/\/doi.org\/10.1007\/s00395-011-0235-3","journal-title":"Basic Res Cardiol"},{"key":"725_CR177","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fphys.2014.00484","volume":"5","author":"S Schlossarek","year":"2014","unstructured":"Schlossarek S, Singh SR, Geertz B, Schulz H, Reischmann S, Hubner N, Carrier L (2014) Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy. Front Physiol 5:484. https:\/\/doi.org\/10.3389\/fphys.2014.00484","journal-title":"Front Physiol"},{"key":"725_CR178","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","volume":"139","author":"T Seeger","year":"2019","unstructured":"Seeger T et al (2019) A premature termination codon mutation in MYBPC3 causes hypertrophic cardiomyopathy via chronic activation of nonsense-mediated decay. Circulation 139:799\u2013811. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034624","journal-title":"Circulation"},{"key":"725_CR179","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","volume":"108","author":"CE Seidman","year":"2011","unstructured":"Seidman CE, Seidman JG (2011) Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res 108:743\u2013750. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223834","journal-title":"Circ Res"},{"key":"725_CR180","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.111.300436","volume":"112","author":"V Sequeira","year":"2013","unstructured":"Sequeira V et al (2013) Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res 112:1491\u20131505. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.300436","journal-title":"Circ Res"},{"key":"725_CR181","doi-asserted-by":"publisher","first-page":"12318","DOI":"10.1074\/jbc.M808850200","volume":"284","author":"JF Shaffer","year":"2009","unstructured":"Shaffer JF, Kensler RW, Harris SP (2009) The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner. J Biol Chem 284:12318\u201312327. https:\/\/doi.org\/10.1074\/jbc.M808850200","journal-title":"J Biol Chem"},{"key":"725_CR182","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Inoue H, Wu JC, Yamanaka S (2017) Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 16:115\u2013130. https:\/\/doi.org\/10.1038\/nrd.2016.245","journal-title":"Nat Rev Drug Discov"},{"key":"725_CR183","doi-asserted-by":"publisher","first-page":"4508470","DOI":"10.1155\/2019\/4508470","volume":"2019","author":"TP Silva","year":"2019","unstructured":"Silva TP, Cotovio JP, Bekman E, Carmo-Fonseca M, Cabral JMS, Fernandes TG (2019) Design principles for pluripotent stem cell-derived organoid engineering. Stem Cells Int 2019:4508470. https:\/\/doi.org\/10.1155\/2019\/4508470","journal-title":"Stem Cells Int"},{"key":"725_CR184","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/qjmed\/81.3.1021","volume":"81","author":"D Simmons","year":"1991","unstructured":"Simmons D, Williams DR, Powell MJ (1991) The Coventry Diabetes Study: prevalence of diabetes and impaired glucose tolerance in Europids and Asians. Q J Med 81:1021\u20131030","journal-title":"Q J Med"},{"key":"725_CR185","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1469-1809.2010.00561.x","volume":"74","author":"TS Simonson","year":"2010","unstructured":"Simonson TS et al (2010) Limited distribution of a cardiomyopathy-associated variant in India. Ann Hum Genet 74:184\u2013188. https:\/\/doi.org\/10.1111\/j.1469-1809.2010.00561.x","journal-title":"Ann Hum Genet"},{"key":"725_CR186","first-page":"243","volume":"12","author":"RJ Solaro","year":"2009","unstructured":"Solaro RJ (2009) CK-1827452, a sarcomere-directed cardiac myosin activator for acute and chronic heart disease. IDrugs 12:243\u2013251","journal-title":"IDrugs"},{"key":"725_CR187","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM199703133361107","volume":"336","author":"P Spirito","year":"1997","unstructured":"Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775\u2013785. https:\/\/doi.org\/10.1056\/NEJM199703133361107","journal-title":"N Engl J Med"},{"key":"725_CR188","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s0022-2836(03)00781-2","volume":"331","author":"JM Squire","year":"2003","unstructured":"Squire JM, Luther PK, Knupp C (2003) Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain. J Mol Biol 331:713\u2013724. https:\/\/doi.org\/10.1016\/s0022-2836(03)00781-2","journal-title":"J Mol Biol"},{"key":"725_CR189","doi-asserted-by":"publisher","first-page":"e24123","DOI":"10.1371\/journal.pone.0024123","volume":"6","author":"A Srivastava","year":"2011","unstructured":"Srivastava A, Garg N, Mittal T, Khanna R, Gupta S, Seth PK, Mittal B (2011) Association of 25 bp deletion in MYBPC3 gene with left ventricle dysfunction in coronary artery disease patients. PLoS One 6:e24123. https:\/\/doi.org\/10.1371\/journal.pone.0024123","journal-title":"PLoS One"},{"key":"725_CR190","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0014-5793(71)80075-3","volume":"15","author":"R Starr","year":"1971","unstructured":"Starr R, Offer G (1971) Polypeptide chains of intermediate molecular weight in myosin preparations. FEBS Lett 15:40\u201344. https:\/\/doi.org\/10.1016\/0014-5793(71)80075-3","journal-title":"FEBS Lett"},{"key":"725_CR191","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1529\/biophysj.105.078147","volume":"90","author":"JE Stelzer","year":"2006","unstructured":"Stelzer JE, Fitzsimons DP, Moss RL (2006) Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. Biophys J 90:4119\u20134127. https:\/\/doi.org\/10.1529\/biophysj.105.078147","journal-title":"Biophys J"},{"key":"725_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1\u20139. https:\/\/doi.org\/10.1007\/s00439-013-1358-4","journal-title":"Hum Genet"},{"key":"725_CR193","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrcardio.2016.139","volume":"14","author":"A Strong","year":"2017","unstructured":"Strong A, Musunuru K (2017) Genome editing in cardiovascular diseases. Nat Rev Cardiol 14:11\u201320. https:\/\/doi.org\/10.1038\/nrcardio.2016.139","journal-title":"Nat Rev Cardiol"},{"key":"725_CR194","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.111.243956","volume":"110","author":"PD Swaminathan","year":"2012","unstructured":"Swaminathan PD, Purohit A, Hund TJ, Anderson ME (2012) Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res 110:1661\u20131677. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.243956","journal-title":"Circ Res"},{"key":"725_CR195","doi-asserted-by":"publisher","unstructured":"Tabish AM, Arif M, Song T, Elbeck Z, Becker RC, Knoll R, Sadayappan S (2019) Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 317:H168-H180 https:\/\/doi.org\/10.1152\/ajpheart.00758.2018","DOI":"10.1152\/ajpheart.00758.2018"},{"key":"725_CR196","doi-asserted-by":"publisher","first-page":"e001263","DOI":"10.1161\/JAHA.114.001263","volume":"3","author":"A Tanaka","year":"2014","unstructured":"Tanaka A et al (2014) Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J Am Heart Assoc 3:e001263. https:\/\/doi.org\/10.1161\/JAHA.114.001263","journal-title":"J Am Heart Assoc"},{"key":"725_CR197","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1517\/13543784.12.11.1791","volume":"12","author":"WH Tang","year":"2003","unstructured":"Tang WH, Francis GS (2003) Novel pharmacological treatments for heart failure. Expert Opin Investig Drugs 12:1791\u20131801. https:\/\/doi.org\/10.1517\/13543784.12.11.1791","journal-title":"Expert Opin Investig Drugs"},{"key":"725_CR198","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.5888\/pcd9.110284","volume":"9","author":"JW Tang","year":"2012","unstructured":"Tang JW, Mason M, Kushner RF, Tirodkar MA, Khurana N, Kandula NR (2012) South Asian American perspectives on overweight, obesity, and the relationship between weight and health. Prev Chronic Dis 9:E107. https:\/\/doi.org\/10.5888\/pcd9.110284","journal-title":"Prev Chronic Dis"},{"key":"725_CR199","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0828-282x(08)70568-3","volume":"24","author":"RR Tanjore","year":"2008","unstructured":"Tanjore RR, Rangaraju A, Kerkar PG, Calambur N, Nallari P (2008) MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India. Can J Cardiol 24:127\u2013130. https:\/\/doi.org\/10.1016\/s0828-282x(08)70568-3","journal-title":"Can J Cardiol"},{"key":"725_CR200","doi-asserted-by":"publisher","first-page":"e002836","DOI":"10.1161\/JAHA.115.002836","volume":"5","author":"EN Taylor","year":"2016","unstructured":"Taylor EN et al (2016) Alterations in multi-scale cardiac architecture in association with phosphorylation of myosin binding protein-C. J Am Heart Assoc 5:e002836. https:\/\/doi.org\/10.1161\/JAHA.115.002836","journal-title":"J Am Heart Assoc"},{"key":"725_CR201","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10741-009-9135-0","volume":"14","author":"JR Teerlink","year":"2009","unstructured":"Teerlink JR (2009) A novel approach to improve cardiac performance: cardiac myosin activators. Heart Fail Rev 14:289\u2013298. https:\/\/doi.org\/10.1007\/s10741-009-9135-0","journal-title":"Heart Fail Rev"},{"key":"725_CR202","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2350-13-105","volume":"13","author":"CH Teirlinck","year":"2012","unstructured":"Teirlinck CH et al (2012) A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death. BMC Med Genet 13:105. https:\/\/doi.org\/10.1186\/1471-2350-13-105","journal-title":"BMC Med Genet"},{"key":"725_CR203","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0092-8674(94)90054-x","volume":"77","author":"L Thierfelder","year":"1994","unstructured":"Thierfelder L et al (1994) Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77:701\u2013712. https:\/\/doi.org\/10.1016\/0092-8674(94)90054-x","journal-title":"Cell"},{"key":"725_CR204","doi-asserted-by":"publisher","first-page":"583170","DOI":"10.1155\/2012\/583170","volume":"2012","author":"EB Thorp","year":"2012","unstructured":"Thorp EB (2012) The myocardial unfolded protein response during ischemic cardiovascular disease. Biochem Res Int 2012:583170. https:\/\/doi.org\/10.1155\/2012\/583170","journal-title":"Biochem Res Int"},{"key":"725_CR205","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2741\/2679","volume":"13","author":"R Tissier","year":"2008","unstructured":"Tissier R, Berdeaux A, Ghaleh B, Couvreur N, Krieg T, Cohen MV, Downey JM (2008) Making the heart resistant to infarction: how can we further decrease infarct size? Front Biosci 13:284\u2013301","journal-title":"Front Biosci"},{"key":"725_CR206","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/CIRCRESAHA.118.314505","volume":"124","author":"CN Toepfer","year":"2019","unstructured":"Toepfer CN et al (2019a) SarcTrack Circ Res 124:1172\u20131183. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.314505","journal-title":"SarcTrack Circ Res"},{"key":"725_CR207","doi-asserted-by":"publisher","unstructured":"Toepfer CN et al (2019b) Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin. Sci Transl Med 11. https:\/\/doi.org\/10.1126\/scitranslmed.aat1199","DOI":"10.1126\/scitranslmed.aat1199"},{"key":"725_CR208","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/CIRCRESAHA.108.177683","volume":"103","author":"CW Tong","year":"2008","unstructured":"Tong CW, Stelzer JE, Greaser ML, Powers PA, Moss RL (2008) Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function. Circ Res 103:974\u2013982. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.177683","journal-title":"Circ Res"},{"key":"725_CR209","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/CIRCHEARTFAILURE.114.001585","volume":"8","author":"CW Tong","year":"2015","unstructured":"Tong CW et al (2015) Phosphoregulation of cardiac inotropy via myosin binding protein-C during increased pacing frequency or beta1-adrenergic stimulation. Circ Heart Fail 8:595\u2013504. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001585","journal-title":"Circ Heart Fail"},{"key":"725_CR210","first-page":"45","volume":"12","author":"CR Uppaluri","year":"2002","unstructured":"Uppaluri CR (2002) Heart disease and its related risk factors in Asian Indians. Ethn Dis 12:45\u201353","journal-title":"Ethn Dis"},{"key":"725_CR211","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","volume":"119","author":"SJ van Dijk","year":"2009","unstructured":"van Dijk SJ et al (2009) Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119:1473\u20131483. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.838672","journal-title":"Circulation"},{"key":"725_CR212","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","volume":"44","author":"SL Van Driest","year":"2004","unstructured":"Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ (2004) Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44:1903\u20131910. https:\/\/doi.org\/10.1016\/j.jacc.2004.07.045","journal-title":"J Am Coll Cardiol"},{"key":"725_CR213","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0025-6196(11)63196-0","volume":"80","author":"SL Van Driest","year":"2005","unstructured":"Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ (2005) Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 80:463\u2013469. https:\/\/doi.org\/10.1016\/S0025-6196(11)63196-0","journal-title":"Mayo Clin Proc"},{"key":"725_CR214","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1157\/13076418","volume":"58","author":"E Vazquez Ruiz de Castroviejo","year":"2005","unstructured":"Vazquez Ruiz de Castroviejo E et al (2005) Analysis of the frequency of cardiac arrhythmias and conduction disturbances from a health-care perspective. Rev Esp Cardiol 58:657\u2013665","journal-title":"Rev Esp Cardiol"},{"key":"725_CR215","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","volume":"105","author":"N Vignier","year":"2009","unstructured":"Vignier N et al (2009) Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice. Circ Res 105:239\u2013248. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.201251","journal-title":"Circ Res"},{"key":"725_CR216","doi-asserted-by":"publisher","first-page":"e0187948","DOI":"10.1371\/journal.pone.0187948","volume":"12","author":"SK Viswanathan","year":"2017","unstructured":"Viswanathan SK, Sanders HK, McNamara JW, Jagadeesan A, Jahangir A, Tajik AJ, Sadayappan S (2017) Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. PLoS One 12:e0187948. https:\/\/doi.org\/10.1371\/journal.pone.0187948","journal-title":"PLoS One"},{"key":"725_CR217","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamacardio.2018.0618","volume":"3","author":"SK Viswanathan","year":"2018","unstructured":"Viswanathan SK et al (2018) Association of cardiomyopathy with MYBPC3 D389V and MYBPC3Delta25bpIntronic deletion in South Asian descendants. JAMA Cardiol 3:481\u2013488. https:\/\/doi.org\/10.1001\/jamacardio.2018.0618","journal-title":"JAMA Cardiol"},{"key":"725_CR218","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","volume":"138","author":"AS Volgman","year":"2018","unstructured":"Volgman AS et al (2018) Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association. Circulation 138:e1\u2013e34. https:\/\/doi.org\/10.1161\/CIR.0000000000000580","journal-title":"Circulation"},{"key":"725_CR219","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0022-2828(03)00050-6","volume":"35","author":"S Waldmuller","year":"2003","unstructured":"Waldmuller S et al (2003) Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 35:623\u2013636","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR220","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.11.006","volume":"71","author":"X Wang","year":"2014","unstructured":"Wang X, Robbins J (2014) Proteasomal and lysosomal protein degradation and heart disease. J Mol Cell Cardiol 71:16\u201324. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.11.006","journal-title":"J Mol Cell Cardiol"},{"key":"725_CR221","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng0493-333","volume":"3","author":"H Watkins","year":"1993","unstructured":"Watkins H et al (1993) A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 3:333\u2013337. https:\/\/doi.org\/10.1038\/ng0493-333","journal-title":"Nat Genet"},{"key":"725_CR222","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ng1295-434","volume":"11","author":"H Watkins","year":"1995","unstructured":"Watkins H et al (1995) Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11:434\u2013437. https:\/\/doi.org\/10.1038\/ng1295-434","journal-title":"Nat Genet"},{"key":"725_CR223","doi-asserted-by":"publisher","first-page":"8999","DOI":"10.1073\/pnas.93.17.8999","volume":"93","author":"A Weisberg","year":"1996","unstructured":"Weisberg A, Winegrad S (1996) Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci U S A 93:8999\u20139003. https:\/\/doi.org\/10.1073\/pnas.93.17.8999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"725_CR224","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.1074\/jbc.M113.541128","volume":"289","author":"N Witayavanitkul","year":"2014","unstructured":"Witayavanitkul N et al (2014) Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium. J Biol Chem 289:8818\u20138827. https:\/\/doi.org\/10.1074\/jbc.M113.541128","journal-title":"J Biol Chem"},{"key":"725_CR225","doi-asserted-by":"publisher","first-page":"e001879","DOI":"10.1161\/JAHA.115.001879","volume":"4","author":"W Wu","year":"2015","unstructured":"Wu W et al (2015) Novel phenotype-genotype correlations of restrictive cardiomyopathy with myosin-binding protein C (MYBPC3) gene mutations tested by next-generation sequencing. J Am Heart Assoc 4:e001879. https:\/\/doi.org\/10.1161\/JAHA.115.001879","journal-title":"J Am Heart Assoc"},{"key":"725_CR226","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1136\/hrt.2007.127241","volume":"94","author":"K Zahka","year":"2008","unstructured":"Zahka K et al (2008) Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish. Heart 94:1326\u20131330. https:\/\/doi.org\/10.1136\/hrt.2007.127241","journal-title":"Heart"}],"container-title":["Biophysical Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-020-00725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12551-020-00725-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-020-00725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T23:32:04Z","timestamp":1626046324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12551-020-00725-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,12]]},"references-count":226,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s12551-020-00725-1","relation":{},"ISSN":["1867-2450","1867-2469"],"issn-type":[{"value":"1867-2450","type":"print"},{"value":"1867-2469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,12]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Sadayappan provides consulting and collaborative research studies to the Leducq Foundation (CURE-PLAN), Red Saree Inc., Greater Cincinnati Tamil Sangam, AstraZeneca, MyoKardia, Merck, and Amgen, but such work is unrelated to the content of this manuscript. Dr. Becker serves on scientific advisory boards for following: Janssen and DSMB Committees for Ionis Pharmaceuticals, Akcea Therapeutics, and Novartis. Dr. Singh has been a post-doctoral fellow of Amgen, starting from June, 2019 and performs research at the University of Cincinnati. No other disclosures are reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}